Literature DB >> 7970208

Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.

H L West1, G W Rebeck, B T Hyman.   

Abstract

Recent data have demonstrated genetic disequilibrium between inheritance of the apolipoprotein E (apoE) epsilon 4 allele and increased risk of Alzheimer disease. We tested the idea that inheritance of other allelic variations of apoE might also increase or decrease the risk of developing Alzheimer disease. We studied apoE genotypes in a large clinic based population of Alzheimer disease patients and age-compatible, tested control individuals. We confirm the genetic disequilibrium between apoE epsilon 4 and Alzheimer disease and now report that inheritance of apoE epsilon 2, another common variant of the apolipoprotein E gene, is negatively associated with risk of developing Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970208     DOI: 10.1016/0304-3940(94)91074-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

1.  Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene.

Authors:  P M Greenwood; T Sunderland; J L Friz; R Parasuraman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  The concept of FDG-PET endophenotype in Alzheimer's disease.

Authors:  Emmanuel H During; R S Osorio; F M Elahi; L Mosconi; M J de Leon
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

3.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

4.  A mouse model of chemotherapy-related cognitive impairments integrating the risk factors of aging and APOE4 genotype.

Authors:  Tamar C Demby; Olga Rodriguez; Camryn W McCarthy; Yi-Chien Lee; Christopher Albanese; Jeanne Mandelblatt; G William Rebeck
Journal:  Behav Brain Res       Date:  2020-02-03       Impact factor: 3.332

5.  APOEε2 is associated with milder clinical and pathological Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Jing Qian; Sarah E Monsell; Rebecca A Betensky; Bradley T Hyman
Journal:  Ann Neurol       Date:  2015-06       Impact factor: 10.422

6.  Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data.

Authors:  Farid Radmanesh; William J Devan; Christopher D Anderson; Jonathan Rosand; Guido J Falcone
Journal:  Eur J Hum Genet       Date:  2014-01-22       Impact factor: 4.246

Review 7.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

8.  A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus.

Authors:  A R Templeton
Journal:  Genetics       Date:  1995-05       Impact factor: 4.562

9.  Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain.

Authors:  Eloise Hudry; Jonathan Dashkoff; Alysson D Roe; Shuko Takeda; Robert M Koffie; Tadafumi Hashimoto; Maria Scheel; Tara Spires-Jones; Michal Arbel-Ornath; Rebecca Betensky; Beverly L Davidson; Bradley T Hyman
Journal:  Sci Transl Med       Date:  2013-11-20       Impact factor: 17.956

10.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.